New treatment strategies for ulcerative colitis

J Panés, I Alfaro - Expert Review of Clinical Immunology, 2017 - Taylor & Francis
… Now, more comprehensive knowledge in the field is possible thanks to efficient sequencing
of human … New drugs for treatment of ulcerative colitis in progress to phase III trials in IBD. …

Cost-effectiveness of different strategies for the treatment of moderate-to-severe ulcerative colitis

B Wu, Z Wang, Q Zhang - Inflammatory Bowel Diseases, 2018 - academic.oup.com
… Janus kinase inhibitor (JAKi) therapies for the treatment of ulcerative colitis (UC) is limited.
We … -AMi), and oral JAKi therapies for the treatment of UC from the perspectives of the United …

Efficient early drug development for ulcerative colitis

R Khanna, V Jairath, NV Casteele, MH Mosli… - …, 2016 - gastrojournal.org
… Although multiple drugs are approved for the treatment of ulcerative colitis (UC), new
agents are required for patients who are unresponsive to conventional management (…

Comparison of the efficiency of different enemas on patients with distal ulcerative colitis

Y Zhang, D Chen, F Wang, X Li, X Xue… - Cell …, 2019 - Wiley Online Library
… involving the questionnaire and treatment choices for distal active ulcerative colitis. A, A …
with topical steroids and 5-ASA to treat left-sided colitis patients. The corresponding number and …

Ulcerative colitis: current and future treatment strategies

D Lissner, B Siegmund - Digestive Diseases, 2013 - karger.com
… a clear pathway on how to treat ulcerative colitis [1]. Despite … moderately severe to severe
ulcerative colitis. Following up on … This indicates that this strategy is efficient to induce a better …

[HTML][HTML] An update on current pharmacotherapeutic options for the treatment of ulcerative colitis

F Ferretti, R Cannatelli, MC Monico, G Maconi… - Journal of Clinical …, 2022 - mdpi.com
treatment. The aim of this review is to summarize current therapeutic strategies used as
treatment for ulcerative colitis … scheduled protocol seem to be efficient for reducing the probability …

[HTML][HTML] Current new challenges in the management of ulcerative colitis

T Fukuda, M Naganuma, T Kanai - Intestinal research, 2019 - ncbi.nlm.nih.gov
… new treatments. In this issue, the features and treatment options for these new treatments is
… by optimizing dose and interval, results in a more efficient use of the drug. Furthermore, after …

Management and treatment optimization of patients with mild to moderate ulcerative colitis

F D'Amico, E Fasulo, V Jairath… - Expert Review of …, 2024 - Taylor & Francis
Introduction Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a significant
health-care burden worldwide. While medical therapy aims to induce and maintain …

Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis

M Naeem, J Lee, MA Oshi, J Cao, SP Hlaing, E Im… - Acta Biomaterialia, 2020 - Elsevier
… in the disrupted epithelium of inflamed colon tissue in ulcerative colitis. However, premature
early drug … This study aimed to develop an advanced colitis-targeted hybrid nanoparticles-in-…

Systematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis

C Trigo-Vicente, V Gimeno-Ballester… - International Journal of …, 2018 - Springer
… Due to this, the efficiency of the treatments is required to make the best decisions and provide
patients the best therapy regimens. In this study, infliximab was showed to be the best in …